Amundi
- SEC CIK
- 0001330387
- Latest filing
- Aug 26, 2026
PTGX holding history
Protagonist Therapeutics, Inc in every 13F filed by Amundi, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PTGX overviewAll 13F holders of PTGXFull Q2 2026 holdings
- Shares (Q2 2026)
- 7,692
- Value
- $942.9K
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 7,692 | $942.9K | <0.1% | +3,579+87.0% | Added | Holders |
| Q1 2026 | 4,113 | $433.5K | <0.1% | +4,113 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −2,058−100.0% | Sold out | Holders |
| Q1 2025 | 2,058 | $95.7K | <0.1% | +25+1.2% | Added | Holders |
| Q4 2024 | 2,033 | $76.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 2,033 | $89.4K | <0.1% | −674−24.9% | Reduced | Holders |
| Q2 2024 | 2,707 | $93.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 2,707 | $68.3K | <0.1% | +675+33.2% | Added | Holders |
| Q4 2023 | 2,032 | $51.6K | <0.1% | −1,687−45.4% | Reduced | Holders |
| Q3 2023 | 3,719 | $57.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 3,719 | $83.0K | <0.1% | +3,719 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −3,855−100.0% | Sold out | Holders |
| Q1 2022 | 3,855 | $98.0K | <0.1% | −198−4.9% | Reduced | Holders |
| Q4 2021 | 4,053 | $141.0K | <0.1% | +4,053 | New | Holders |